Myocardial energetics and efficiency: Current status of the noninvasive approach

Circulation

Volumn 115, Issue 7, 2007, Pages 918-927

  Knaapen, Paul ^a,c   Germans, Tjeerd ^a   Knuuti, Juhani ^b   Paulus, Walter J ^a   Dijkmans, Pieter A ^a   Allaart, Cornelis P ^a   Lammertsma, Adriaan A ^a   Visser, Frans C ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF TURKU   (Finland)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Hemodynamics; Imaging; Metabolism

Indexed keywords

AEROBIC METABOLISM; CARDIOVASCULAR PARAMETERS; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY DISEASE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE; HEART MUSCLE OXYGEN CONSUMPTION; HEART VENTRICLE PRESSURE; HEART VOLUME; HEART WORK; HUMAN; NON INVASIVE MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; REVIEW;

BIOMECHANICS; CARDIOVASCULAR DISEASES; ENERGY METABOLISM; HEART CATHETERIZATION; HUMANS; OXIDATIVE STRESS; OXYGEN CONSUMPTION;

EID: 33847141025     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.106.660639     Document Type: Review

References (65)

1. Braunwald E. Control of myocardial oxygen consumption: physiologic and clinical considerations. Am J Cardiol. 1971;27:416-432.
2. Bing RJ, Hammond M, Handelsman JC, Powers RS, Spencer F, Eckenhoff JE, Goodale WT, Hafkenschiel J, Kety SS. The measurement of coronary blood flow, oxygen consumption, and efficiency of the left ventricle in man. Am Heart J. 1949;38:1-24.
3. Suga H. Ventricular energetics. Physiol Rev. 1990;70:247-277.
4. Katz AM. Cardiomyopathy of overload: a major determinant of prognosis in congestive heart failure. N Engl J Med. 1990;322:100-110.
5. Ingwall JS, Weiss RG. Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ Res. 2004;95:135-145.
6. Eichhorn EJ, Bristow MR. Medical therapy can improve the biological properties of the chronically failing heart: a new era in the treatment of heart failure. Circulation. 1996;94:2285-2296.
7. Fick A. Über die Messung den Blutquantums in der Herzventrikeln. Sitzungb Phys Med Ges Würzburg. 1870;16.
8. Gibbs CL. Cardiac energetics. Physiol Rev. 1978;58:174-254.
9. Arnoult F, Loiseau A, Aptecar E, Loisance D, Nitenberg A. Ventriculoarterial coupling and left ventricular efficiency in heart transplant recipients. Transplantation. 1997;64:617-626.
10. Nichols AB, Pearson MH, Sciacca RR, Cannon PJ. Left ventricular mechanical efficiency in coronary artery disease. J Am Coll Cardiol. 1986;7:270-279.
11. ten Velden GH, Elzinga G, Westerhof N. Left ventricular energetics: heat loss and temperature distribution of canine myocardium. Circ Res. 1982;50:63-73.
12. Gropler RJ. Noninvasive measurements of myocardial oxygen consumption-can we do better? J Am Coll Cardiol. 2003;41:468-470.
13. Klein LJ, Visser FC, Knaapen P, Peters JH, Teule GJ, Visser CA, Lammertsma AA. Carbon-11 acetate as a tracer of myocardial oxygen consumption. Eur J Nucl Med. 2001;28:651-668.
14. Iida H, Rhodes CG, Araujo LI, Yamamoto Y, de Silva R, Maseri A, Jones T. Noninvasive quantification of regional myocardial metabolic rate for oxygen by use of 15O2 inhalation and positron emission tomography: theory, error analysis, and application in humans. Circulation. 1996;94:792-807.
15. Yamamoto Y, de Silva R, Rhodes CG, Iida H, Lammertsma AA, Jones T, Maseri A. Noninvasive quantification of regional myocardial metabolic rate of oxygen by 15O2 inhalation and positron emission tomography: experimental validation. Circulation. 1996;94:808-816.
16. Armbrecht JJ, Buxton DB, Schelbert HR. Validation of [1-11C]acetate as a tracer for noninvasive assessment of oxidative metabolism with positron emission tomography in normal, ischemic, postischemic, and hyperemic canine myocardium. Circulation. 1990;81:1594-1605.
17. Iida H, Jones T, Miura S. Modeling approach to eliminate the need to separate arterial plasma in oxygen-15 inhalation positron emission tomography. J Nucl Med. 1993;34:1333-1340.
18. Bellenger NG, Burgess MI, Ray SG, Lahiri A, Coats AJ, Cleland JG, Pennell DJ. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance: are they interchangeable? Eur Heart J. 2000;21:1387-1396.
19. Kelly RP, Ting CT, Yang TM, Liu CP, Maughan WL, Chang MS, Kass DA. Effective arterial elastance as index of arterial vascular load in humans. Circulation. 1992;86:513-521.
20. Porenta G, Cherry S, Czernin J, Brunken R, Kuhle W, Hashimoto T, Schelbert HR. Noninvasive determination of myocardial blood flow, oxygen consumption and efficiency in normal humans by carbon-11 acetate positron emission tomography imaging. Eur J Nucl Med. 1999;26:1465-1474.
21. Beanlands RS, Bach DS, Raylman R, Armstrong WF, Wilson V, Montieth M, Moore CK, Bates E, Schwaiger M. Acute effects of dobutamine on myocardial oxygen consumption and cardiac efficiency measured using carbon-11 acetate kinetics in patients with dilated cardiomyopathy. J Am Coll Cardiol. 1993;22:1389-1398.
22. Schulz R, Kappeler C, Coenen H, Bockisch A, Heusch G. Positron emission tomography analysis of [1-(11)C] acetate kinetics in short-term hibernating myocardium. Circulation. 1998;97:1009-1016.
23. Buck A, Wolpers HG, Hutchins GD, Savas V, Mangner TJ, Nguyen N, Schwaiger M. Effect of carbon-11-acetate recirculation on estimates of myocardial oxygen consumption by PET. J Nucl Med. 1991;32:1950-1957.
24. Sun KT, Yeatman LA, Buxton DB, Chen K, Johnson JA, Huang SC, Kofoed KF, Weismueller S, Czernin J, Phelps ME, Schelbert HR. Simultaneous measurement of myocardial oxygen consumption and blood flow using [1-carbon-11]acetate. J Nucl Med. 1998;39:272-280.
25. Essop MF, Opie LH. Metabolic therapy for heart failure. Eur Heart J. 2004;25:1765-1768.
26. Currie PJ, Seward JB, Reeder GS, Vlietstra RE, Bresnahan DR, Bresnahan JF, Smith HC, Hagler DJ, Tajik AJ. Continuous-wave Doppler echocardiographic assessment of severity of calcific aortic stenosis: a simultaneous Doppler-catheter correlative study in 100 adult patients. Circulation. 1985;71:1162-1169.
27. Bouchard A, Blumlein S, Schiller NB, Schlitt S, Byrd BF 3rd, Ports T, Chatterjee K. Measurement of left ventricular stroke volume using continuous wave Doppler echocardiography of the ascending aorta and M-mode echocardiography of the aortic valve. J Am Coll Cardiol. 1987;9:75-83.
28. Rebergen SA, van der Wall EE, Doornbos J, de Roos A. Magnetic resonance measurement of velocity and flow: technique, validation, and cardiovascular applications. Am Heart J. 1993;126:1439-1456.
29. Sugeng L, Mor-Avi V, Weinert L, Niel J, Ebner C, Steringer-Mascherbauer R, Schmidt F, Galuschky C, Schummers G, Lang RM, Nesser HJ. Quantitative assessment of left ventricular size and function: side-by-side comparison of real-time three-dimensional echocardiography and computed tomography with magnetic resonance reference. Circulation. 2006;114:654-661.
30. Corsi C, Coon P, Goonewardena S, Weinert L, Sugeng L, Polonsky TS, Veronesi F, Caiani EG, Lamberti C, Bardo D, Lang RM, Mor-Avi V. Quantification of regional left ventricular wall motion from real-time 3-dimensional echocardiography in patients with poor acoustic windows: effects of contrast enhancement tested against cardiac magnetic resonance. J Am Soc Echocardiogr. 2006;19:886-893.
31. Vanoverschelde JL, Wijns W, Essamri B, Bol A, Robert A, Labar D, Cogneau M, Michel C, Melin JA. Hemodynamic and mechanical determinants of myocardial O2 consumption in normal human heart: effects of dobutamine. Am J Physiol. 1993;265:H1884-H1892.
32. Takala TO, Nuutila P, Katoh C, Luotolahti M, Bergman J, Maki M, Oikonen V, Ruotsalainen U, Gronroos T, Haaparanta M, Kapanen J, Knuuti J. Myocardial blood flow, oxygen consumption, and fatty acid uptake in endurance athletes during insulin stimulation. Am J Physiol. 1999;277:E585-E590.
33. Laine H, Katoh C, Luotolahti M, Yki-Jarvinen H, Kantola I, Jula A, Takala TO, Ruotsalainen U, Iida H, Haaparanta M, Nuutila P, Knuuti J. Myocardial oxygen consumption is unchanged but efficiency is reduced in patients with essential hypertension and left ventricular hypertrophy. Circulation. 1999;100:2425-2430.
34. Akinboboye OO, Chou RL, Bergmann SR. Myocardial blood flow and efficiency in concentric and eccentric left ventricular hypertrophy. Am J Hypertens. 2004;17:433-438.
35. Peterson LR, Herrero P, Schechtman KB, Racette SB, Waggoner AD, Kisrieva-Ware Z, Dence C, Klein S, Marsala J, Meyer T, Gropler RJ. Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation. 2004;109:2191-2196.
36. Nakano K, Sugawara M, Kato T, Sasayama S, Carabello BA, Asanoi H, Umemura J, Koyanagi H. Regional work of the human left ventricle calculated by wall stress and the natural logarithm of reciprocal of wall thickness. J Am Coll Cardiol. 1988;12:1442-1448.
37. Gotte MJ, van Rossum AC, Marcus JT, Kuijer JP, Axel L, Visser CA. Recognition of infarct localization by specific changes in intramural myocardial mechanics. Am Heart J. 1999;138:1038-1045.
38. Gerber BL, Wijns W, Vanoverschelde JL, Heyndrickx GR, De Bruyne B, Bartunek J, Melin JA. Myocardial perfusion and oxygen consumption in reperfused noninfarcted dysfunctional myocardium after unstable angina: direct evidence for myocardial stunning in humans. J Am Coll Cardiol. 1999;34:1939-1946.
39. Vanoverschelde JL, Wijns W, Depre C, Essamri B, Heyndrickx GR, Borgers M, Bol A, Melin JA. Mechanisms of chronic regional postischemic dysfunction in humans: new insights from the study of noninfarcted collateral-dependent myocardium. Circulation. 1993;87:1513-1523.
40. Barnes E, Hall RJ, Dutka DP, Camici PG. Absolute blood flow and oxygen consumption in stunned myocardium in patients with coronary artery disease. J Am Coll Cardiol. 2002;39:420-427.
41. Vanoverschelde JL, Wijns W, Borgers M, Heyndrickx G, Depre C, Flameng W, Melin JA. Chronic myocardial hibernation in humans: from bedside to bench. Circulation. 1997;95:1961-1971.
42. Gerber BL, Laycock S, Melin JA, Borgers M, Flameng W, Vanoverschelde JL. Myocardial blood flow, metabolism, and inotropic reserve in dogs with dysfunctional noninfarcted collateral-dependent myocardium. J Nucl Med. 2002;43:556-565.
43. Gropler RJ, Geltman EM, Sampathkumaran K, Perez JE, Moerlein SM, Sobel BE, Bergmann SR, Siegel BA. Functional recovery after coronary revascularization for chronic coronary artery disease is dependent on maintenance of oxidative metabolism. J Am Coll Cardiol. 1992;20:569-577.
44. Wolpers HG, Burchert W, van den HJ, Weinhardt R, Meyer GJ, Lichtlen PR. Assessment of myocardial viability by use of 11C-acetate and positron emission tomography: threshold criteria of reversible dysfunction. Circulation. 1997;95:1417-1424.
45. Bonow RO. Myocardial viability and prognosis in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol. 2002;39:1159-1162.
46. Vitale C, Wajngaten M, Sposato B, Gebara O, Rossini P, Fini M, Volterrani M, Rosano GM. Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease. Eur Heart J. 2004;25:1814-1821.
47. Kim IS, Izawa H, Sobue T, Ishihara H, Somura F, Nishizawa T, Nagata K, Iwase M, Yokota M. Prognostic value of mechanical efficiency in ambulatory patients with idiopathic dilated cardiomyopathy in sinus rhythm. J Am Coll Cardiol. 2002;39:1264-1268.
48. Hayashi Y, Takeuchi M, Takaoka H, Hata K, Mori M, Yokoyama M. Alteration in energetics in patients with left ventricular dysfunction after myocardial infarction: increased oxygen cost of contractility. Circulation. 1996;93:932-939.
49. Braunwald E, Bristow MR. Congestive heart failure: fifty years of progress. Circulation. 2000;102:IV14-IV23.
50. Wolpers HG, Buck A, Nguyen N, Marcowitz PA, Armstrong WF, Starling MR, Hicks R, Mangner TJ, Schwaiger M. An approach to ventricular efficiency by use of carbon 11-labeled acetate and positron emission tomography. J Nucl Cardiol. 1994;1:262-269.
51. Hall SA, Cigarroa CG, Marcoux L, Risser RC, Grayburn PA, Eichhorn EJ. Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade. J Am Coll Cardiol. 1995;25:1154-1161.
52. Eichhorn EJ, Heesch CM, Barnett JH, Alvarez LG, Fass SM, Grayburn PA, Hatfield BA, Marcoux LG, Malloy CR. Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol. 1994;24:1310-1320.
53. Beanlands RS, Nahmias C, Gordon E, Coates G, deKemp R, Firnau G, Fallen E. The effects of beta(1)-blockade on oxidative metabolism and the metabolic cost of ventricular work in patients with left ventricular dysfunction: a double-blind, placebo-controlled, positron-emission tomography study. Circulation. 2000;102:2070-2075.
54. Baldasseroni S, Opasich C, Gorini M, Lucci D, Marchionni N, Marini M, Campana C, Perini G, Deorsola A, Masotti G, Tavazzi L, Maggioni AP. Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure. Am Heart J. 2002;143:398-405.
55. Baller D, Wolpers HG, Zipfel J, Hoeft A, Hellige G. Unfavorable effects of ventricular pacing on myocardial energetics. Basic Res Cardiol. 1981;76:115-123.
56. Bax JJ, Abraham T, Barold SS, Breithardt OA, Fung JW, Garrigue S, Gorcsan J 3rd, Hayes DL, Kass DA, Knuuti J, Leclercq C, Linde C, Mark DB, Monaghan MJ, Nihoyannopoulos P, Schalij MJ, Stellbrink C, Yu CM. Cardiac resynchronization therapy: part 1-issues before device implantation. J Am Coll Cardiol. 2005;46:2153-2167.
57. Nelson GS, Berger RD, Fetics BJ, Talbot M, Spinelli JC, Hare JM, Kass DA. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation. 2000;102:3053-3059.
58. Ukkonen H, Beanlands RS, Burwash IG, de Kemp RA, Nahmias C, Fallen E, Hill MR, Tang AS. Effect of cardiac resynchronization on myocardial efficiency and regional oxidative metabolism. Circulation. 2003;107:28-31.
59. Lindner O, Sorensen J, Vogt J, Fricke E, Baller D, Horstkotte D, Burchert W. Cardiac efficiency and oxygen consumption measured with 11C-acetate PET after long-term cardiac resynchronization therapy. J Nucl Med. 2006;47:378-383.
60. Sundell J, Engblom E, Koistinen J, Ylitalo A, Naum A, Stolen KQ, Kalliokoski R, Nekolla SG, Airaksinen KE, Bax JJ, Knuuti J. The effects of cardiac resynchronization therapy on left ventricular function, myocardial energetics, and metabolic reserve in patients with dilated cardiomyopathy and heart failure. J Am Coll Cardiol. 2004;43:1027-1033.
61. Malik AB, Abe T, O'kane H, Geha AS. Cardiac function, coronary flow, and oxygen consumption in stable left ventricular hypertrophy. Am J Physiol. 1973;225:186-191.
62. Schwitter J, Eberli FR, Ritter M, Turina M, Krayenbuehl HP. Myocardial oxygen consumption in aortic valve disease with and without left ventricular dysfunction. Br Heart J. 1992;67:161-169.
63. Hicks RJ, Savas V, Currie PJ, Kalff V, Starling M, Bergin P, Kirsch M, Schwaiger M. Assessment of myocardial oxidative metabolism in aortic valve disease using positron emission tomography with C-11 acetate. Am Heart J. 1992;123:653-664.
64. Chen CH, Fetics B, Nevo E, Rochitte CE, Chiou KR, Ding PA, Kawaguchi M, Kass DA. Noninvasive single-beat determination of left ventricular end-systolic elastance in humans. J Am Coll Cardiol. 2001;38:2028-2034.
65. Klotz S, Hay I, Dickstein ML, Yi GH, Wang J, Maurer MM, Kass DA, Burkhoff D. Single beat estimation of the end-diastolic pressure-volume relationship: a novel method with the potential for noninvasive application. Am J Physiol Heart Circ Physiol. 2006;291:H403-H412.